Cockroach Reduction Intervention for Childhood Asthma
(ARCHS Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. However, it mentions that children with asthma who are on long-term controller medication are eligible to participate, so it seems likely that continuing asthma medication is allowed.
Research shows that using a combination of education, insecticide bait, and professional cleaning can significantly reduce cockroach numbers and allergens in homes, which are known triggers for asthma in children. Additionally, tailored pest management approaches have been successful in reducing cockroach infestations in urban communities, making them a cost-effective solution.
12345The studies focus on reducing cockroach allergens to help with asthma, but they do not provide specific safety data for humans regarding the intervention methods like insecticidal bait or pest control bait.
12367This treatment is unique because it focuses on reducing cockroach exposure, a known asthma trigger, through a tailored approach or insecticidal bait, rather than directly treating asthma symptoms. Unlike standard asthma treatments that often involve medication to manage symptoms, this intervention aims to address an environmental cause of asthma.
378910Eligibility Criteria
The ARCHS trial is for children aged 5-17 in the Greater New Orleans area with uncontrolled persistent asthma and exposure to cockroaches. They must have had recent hospital visits or symptoms due to asthma, sleep at the target home most of the week, and speak English or Spanish. Kids can't join if they smoke, take beta-blockers, have certain heart diseases (except hypertension), other serious illnesses requiring daily meds, are on immunotherapy, or plan to move soon.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of asthma symptoms, quality of life, and cockroach exposure
Treatment
Participants receive either a multi-component intervention or insecticidal bait for cockroach reduction
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
Comparator 1 (tailored approach) is already approved in United States for the following indications:
- Asthma Management
- Allergy Prevention